These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 23957267)

  • 41. Engineering liposomes for drug delivery: progress and problems.
    Gregoriadis G
    Trends Biotechnol; 1995 Dec; 13(12):527-37. PubMed ID: 8595139
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Development of liposomal amphotericin B formulation.
    Gulati M; Bajad S; Singh S; Ferdous AJ; Singh M
    J Microencapsul; 1998; 15(2):137-51. PubMed ID: 9532520
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Liposome-based drug delivery of various anticancer agents of synthetic and natural product origin: a patent overview.
    Akhtar N; Mohammed SA; Singh V; Abdellatif AA; Mohammad HA; Ahad A; Yusuf M; Khadri H; Naz M; Khan O; Rashid M; Khan RA
    Pharm Pat Anal; 2020 May; 9(3):87-116. PubMed ID: 32609057
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chitosan-reduced gold nanoparticles: a novel carrier for the preparation of spray-dried liposomes for topical delivery.
    Padamwar MN; Patole MS; Pokharkar VB
    J Liposome Res; 2011 Dec; 21(4):324-32. PubMed ID: 21623705
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Liposomal delivery of proteins and peptides.
    Swaminathan J; Ehrhardt C
    Expert Opin Drug Deliv; 2012 Dec; 9(12):1489-503. PubMed ID: 23092138
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Targeting monocyte and macrophage subpopulations for immunotherapy: a patent review (2009 - 2013).
    Jackson WD; Woollard KJ
    Expert Opin Ther Pat; 2014 Jul; 24(7):779-90. PubMed ID: 24773534
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recent Progress in Liposome Production, Relevance to Drug Delivery and Nanomedicine.
    Koynova R; Tenchov B
    Recent Pat Nanotechnol; 2015; 9(2):86-93. PubMed ID: 27009123
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Radionuclide imaging of liposomal drug delivery.
    van der Geest T; Laverman P; Metselaar JM; Storm G; Boerman OC
    Expert Opin Drug Deliv; 2016 Sep; 13(9):1231-42. PubMed ID: 27351233
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Liposomes as nanocarriers for anti-HIV therapy.
    Chopra S; Venkatesan N; Betageri GV
    Drug Deliv Transl Res; 2013 Oct; 3(5):471-8. PubMed ID: 25788354
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Composition design and medical application of liposomes.
    Li M; Du C; Guo N; Teng Y; Meng X; Sun H; Li S; Yu P; Galons H
    Eur J Med Chem; 2019 Feb; 164():640-653. PubMed ID: 30640028
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Using liposomes to target infection and inflammation induced by foreign body injuries or medical implants.
    Schroeder A; Turjeman K; Schroeder JE; Leibergall M; Barenholz Y
    Expert Opin Drug Deliv; 2010 Oct; 7(10):1175-89. PubMed ID: 20858166
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Liposome technology for drug delivery against mycobacterial infections.
    Khuller GK; Kapur M; Sharma S
    Curr Pharm Des; 2004; 10(26):3263-74. PubMed ID: 15544514
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anticancer patent landscape and technology assessment of Indian public-funded research institutes and organizations.
    Dara A; Sangamwar AT
    Expert Opin Ther Pat; 2014 Aug; 24(8):893-912. PubMed ID: 24898985
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Liposome-ligand conjugates: a review on the current state of art.
    Eroğlu İ; İbrahim M
    J Drug Target; 2020 Mar; 28(3):225-244. PubMed ID: 31339374
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Application of Liposomes in Cancer Therapy: An Assessment of the Advancement of Technology Through Patent Documents.
    Nunes DDG; Leal IL; Oliveira FO; da Silva TLR; de Senna V; Machado BSS
    Recent Pat Nanotechnol; 2021; 15(4):367-376. PubMed ID: 33357205
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Liposome composition in drug delivery design, synthesis, characterization, and clinical application.
    Large DE; Abdelmessih RG; Fink EA; Auguste DT
    Adv Drug Deliv Rev; 2021 Sep; 176():113851. PubMed ID: 34224787
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Stimulus-responsive liposomes for biomedical applications.
    Antoniou AI; Giofrè S; Seneci P; Passarella D; Pellegrino S
    Drug Discov Today; 2021 Aug; 26(8):1794-1824. PubMed ID: 34058372
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Potential application of liposomal nanodevices for non-cancer diseases: an update on design, characterization and biopharmaceutical evaluation.
    Bayat F; Hosseinpour-Moghadam R; Mehryab F; Fatahi Y; Shakeri N; Dinarvand R; Ten Hagen TLM; Haeri A
    Adv Colloid Interface Sci; 2020 Mar; 277():102121. PubMed ID: 32092487
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Therapeutic Applications of Liposomal Based Drug Delivery and Drug Targeting for Immune Linked Inflammatory Maladies: A Contemporary View Point.
    Rahman M; Beg S; Verma A; Kazmi I; Patel DK; Anwar F; Al Abbasi FA; Kumar V
    Curr Drug Targets; 2017; 18(13):1558-1571. PubMed ID: 28413980
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmaceutical liposomal delivery-specific considerations of innovation and challenges.
    Peng T; Xu W; Li Q; Ding Y; Huang Y
    Biomater Sci; 2022 Dec; 11(1):62-75. PubMed ID: 36373563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.